Get the Stockscreener App
28.03
0.36%
0.10
After Hours:
28.03
Progyny Inc stock is traded at $28.03, with a volume of 825.98K.
It is up +0.36% in the last 24 hours and up +2.49% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$27.93
Open:
$27.88
24h Volume:
825.98K
Relative Volume:
0.69
Market Cap:
$2.15B
Revenue:
$1.29B
Net Income/Loss:
$67.69M
P/E Ratio:
36.40
EPS:
0.7701
Net Cash Flow:
$184.42M
1W Performance:
+8.39%
1M Performance:
+2.49%
6M Performance:
+71.96%
1Y Performance:
+39.45%
1-Day Range:
$27.64
$28.17
1-Week Range:
$25.56
$28.32
52-Week Range:
$16.10
$33.06
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
28.03 | 2.15B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
378.52 | 339.76B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
87.74 | 112.22B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
422.09 | 91.54B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
283.34 | 74.87B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
433.50 | 52.05B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-26 | Initiated | Wells Fargo | Overweight |
| Jul-28-26 | Downgrade | Barclays | Overweight → Equal Weight |
| May-19-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock? - Zacks Investment Research
PGNY or CRL: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Progyny, Inc. (PGNY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Officer at Progyny (PGNY) plans about $102K stock sale - Stock Titan
Progyny (PGNY) CPO reports 819-share tax withholding - Stock Titan
Progyny (NASDAQ: PGNY) director sells 11,500 shares after exercising options - Stock Titan
Progyny Director Gordon Kevin K Executes 22,000 Stock Options at $13 Each (NASDAQ: PGNY) - Kalkine Media
Progyny director Kevin Gordon sells $321,358 in company stock By Investing.com - Investing.com Nigeria
Progyny director Kevin Gordon sells $321,358 in company stock By Investing.com - Investing.com Canada
Progyny director Kevin Gordon sells $321,358 in company stock - Investing.com
Progyny Insider Sold Shares Worth $321,358, According to a Recent SEC Filing - Yahoo Finance
Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2 - Yahoo Finance
Progyny (NASDAQ: PGNY) director lines up six-figure stock sale - Stock Titan
Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2 - TradingView
Progyny, Inc. (NASDAQ: PGNY) Insider Swartz Allison Forfeits 1,307 Shares at $26.29-$26.61 Range - Kalkine Media
Progyny CEO Peter Anevski Forfeits 5,361 Shares for Tax Withholding at $26.29 Each - Kalkine Media
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know - Yahoo Finance
Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know - Zacks Investment Research
Progyny at Wells Fargo healthcare conference: growth runway stays wide By Investing.com - Investing.com South Africa
Progyny CFO Mark S. Livingston Reports Share Withholding on RSU Vesting - kalkinemedia.com
Progyny EVP Allison Swartz Reports Tax-Withholding Stock Transactions Following RSU Vesting - Kalkine Media
Progyny CEO Peter Anevski Reports RSU Tax-Withholding Share Disposal in Form 4 Filing - kalkinemedia.com
Progyny (PGNY) CEO uses 5,361 shares to cover taxes - Stock Titan
Progyny (PGNY) CFO reports 479-share tax withholding - Stock Titan
Progyny at Wells Fargo healthcare conference: growth runway stays wide By Investing.com - Investing.com Nigeria
Progyny at Wells Fargo healthcare conference: growth runway stays wide By Investing.com - Investing.com Canada
Progyny at Wells Fargo healthcare conference: growth runway stays wide By Investing.com - Investing.com UK
PGNY Maintains by Citizens -- Price Target Raised to $33.00 - GuruFocus
Citizens JMP Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $33 - moomoo.com
Citizens raises Progyny stock price target on CalPERS contract win By Investing.com - Investing.com South Africa
Citizens raises Progyny stock price target on CalPERS contract win By Investing.com - Investing.com Canada
Citizens raises Progyny stock price target on CalPERS contract win By Investing.com - Investing.com UK
Avoiding Lag: Real-Time Signals in (PGNY) Movement - Stock Traders Daily
Progyny: Slow But Consistent Growth With A Pristine Balance Sheet (NASDAQ:PGNY) - Seeking Alpha
Progyny Inc. (PGNY) Stock Price | Live Quotes & Charts | NASDAQ - Timothy Sykes
CFO at Progyny (PGNY) covers RSU taxes with shares - Stock Titan
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference - Yahoo Finance
Wells Fargo's healthcare conference will feature Progyny's finance chief Sept. 8 - Stock Titan
Progyny stock price target maintained at $31 by Citizens on new offering - Investing.com Canada
Progyny stock price target maintained at $31 by Citizens on new offering - Investing.com UK
Progyny stock price target maintained at $31 by Citizens on new offering - Investing.com
Progyny (PGNY) legal chief covers RSU taxes with shares - Stock Titan
Progyny stock steadies after soft Q2 guidance and revenue growth - AD HOC NEWS
Wells Fargo Conceives a High Rating for the Fertility-Benefits Biz - Yahoo Finance
Progyny (NASDAQ:PGNY) Healthcare Innovation Gains Attention - Kalkine Media
PGNY Maintained by JP Morgan -- Price Target Raised to $30.00 - GuruFocus
JPMorgan Chase & Co. Boosts Progyny (NASDAQ:PGNY) Price Target to $30.00 - MarketBeat
Progyny (NASDAQ:PGNY) Upgraded at Wells Fargo & Company - MarketBeat
Tocqueville Asset Management L.P. Takes Position in Progyny, Inc. $PGNY - MarketBeat
Danske Bank A S Purchases Shares of 528,717 Progyny, Inc. $PGNY - MarketBeat
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Progyny Inc Stock (PGNY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Swartz Allison | Officer |
Sep 23 '26 |
Proposed Sale |
26.10 |
3,903 |
101,868 |
0 |
| GORDON KEVIN K | Director |
Sep 10 '26 |
Option Exercise |
13.00 |
22,000 |
286,000 |
28,792 |
| GORDON KEVIN K | Director |
Sep 10 '26 |
Sale |
27.94 |
11,500 |
321,358 |
6,792 |
| GORDON KEVIN K | Director |
Sep 10 '26 |
Proposed Sale |
27.12 |
11,500 |
311,859 |
0 |
| Cummings Melissa B | Officer |
Jul 14 '26 |
Proposed Sale |
31.60 |
2,244 |
70,910 |
0 |
| Cummings Melissa B | Chief Operating Officer |
Jul 14 '26 |
Sale |
31.60 |
2,244 |
70,910 |
69,934 |
| Livingston Mark S. | Officer |
Jun 04 '26 |
Proposed Sale |
25.50 |
2,517 |
64,184 |
0 |
| Swartz Allison | EVP, GC |
Jun 04 '26 |
Sale |
25.08 |
599 |
15,023 |
82,378 |
| Livingston Mark S. | CHIEF FINANCIAL OFFICER |
Jun 04 '26 |
Sale |
25.50 |
2,517 |
64,184 |
74,688 |
| Swartz Allison | Officer |
Jun 04 '26 |
Proposed Sale |
25.08 |
599 |
15,023 |
0 |
0.21%
7.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):